Cargando…
Optimizing COVID-19 Symptom Screening in the Pediatric Population
Background: Research analyzing COVID-19 symptom screening has primarily focused on adult patients. In efforts to safely reopen schools, symptom screeners are being widely utilized. However, pediatric-specific outpatient data on which symptom combinations best identify children with COVID-19 are lack...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551572/ http://dx.doi.org/10.1017/ash.2021.107 |
_version_ | 1784806133581479936 |
---|---|
author | Zhou, Geena Singh, Prachi Perito, Emily R. Bardach, Naomi Penwill, Nicole Burrough, William Cheung, Ann Nguyen, Margaret Mittal, Shalini Cheng, Grace Spad, Mia-Ashley |
author_facet | Zhou, Geena Singh, Prachi Perito, Emily R. Bardach, Naomi Penwill, Nicole Burrough, William Cheung, Ann Nguyen, Margaret Mittal, Shalini Cheng, Grace Spad, Mia-Ashley |
author_sort | Zhou, Geena |
collection | PubMed |
description | Background: Research analyzing COVID-19 symptom screening has primarily focused on adult patients. In efforts to safely reopen schools, symptom screeners are being widely utilized. However, pediatric-specific outpatient data on which symptom combinations best identify children with COVID-19 are lacking. Such data could refine school symptom screening by improving screener sensitivity and specificity. In this study, we assessed the frequency of symptoms and symptom combinations in children tested for SARS-CoV-2 in outpatient settings. We aim to contribute to the optimization of pediatric COVID-19 screening questionnaires, to ultimately minimize both COVID-19 transmission in schools and missed school days. Methods: We conducted a retrospective analysis of outpatient symptoms screens, SARS-CoV-2 test results, and demographics of children (≤18 years) tested for SARS-CoV-2 between March 30 and November 30, 2020, at 3 UCSF-affiliated COVID-19 outpatient screening clinics in northern California. Those with incomplete symptom screens, >7 days between symptom documentation and test, and invalid test results were excluded. Results: Of 473 children tested at 1 site, 21 children had positive SARs-CoV-2 results and 452 children had negative results (4.4% positivity rate). Moreover, 85.7% of SARS-CoV-2–positive children had a known exposure to COVID-19 (Table 1). Of SARS-CoV-2–positive children, 61.9% had >1 symptom. Also, 52.4% of SARS-CoV-2–positive children had at least 1 symptom (fever, cough, or loss of taste or smell) versus 62.8% of SARS-CoV-2–negative children (Table 2). Runny nose or nasal congestion was the most frequently reported symptom in the SARS-CoV-2–positive group (47.6%) as well as the SARS-CoV-2–negative group (58.6%). Also, 14.3% of SARS-CoV-2–positive children had eye redness or discharge versus 3.1% of SARS-CoV-2–negative children. Isolated runny nose presented in 10.8% of SARS-CoV-2–negative versus 9.5% of SARS-CoV-2–positive children. All children with isolated diarrhea (n = 5), isolated headache (n = 3), and isolated rash (n = 2) tested negative. Preliminary symptom data based on 176 children from a second site showed that 9.9% of symptomatic children had a positive test result. Conclusions: Runny nose or nasal congestion was the most frequently reported symptom in all children tested for SARS-CoV-2. However, isolated runny nose or nasal congestion identified 2 cases of COVID-19 in our cohort. Eye redness or discharge may be an important symptom to screen for COVID-19 in children. Further research with a larger number of positive cases is needed to make conclusions about improving efficiency and efficacy of symptom screeners for COVID-19 in children. Funding: No Disclosures: None |
format | Online Article Text |
id | pubmed-9551572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95515722022-10-12 Optimizing COVID-19 Symptom Screening in the Pediatric Population Zhou, Geena Singh, Prachi Perito, Emily R. Bardach, Naomi Penwill, Nicole Burrough, William Cheung, Ann Nguyen, Margaret Mittal, Shalini Cheng, Grace Spad, Mia-Ashley Antimicrob Steward Healthc Epidemiol Covid-19 Background: Research analyzing COVID-19 symptom screening has primarily focused on adult patients. In efforts to safely reopen schools, symptom screeners are being widely utilized. However, pediatric-specific outpatient data on which symptom combinations best identify children with COVID-19 are lacking. Such data could refine school symptom screening by improving screener sensitivity and specificity. In this study, we assessed the frequency of symptoms and symptom combinations in children tested for SARS-CoV-2 in outpatient settings. We aim to contribute to the optimization of pediatric COVID-19 screening questionnaires, to ultimately minimize both COVID-19 transmission in schools and missed school days. Methods: We conducted a retrospective analysis of outpatient symptoms screens, SARS-CoV-2 test results, and demographics of children (≤18 years) tested for SARS-CoV-2 between March 30 and November 30, 2020, at 3 UCSF-affiliated COVID-19 outpatient screening clinics in northern California. Those with incomplete symptom screens, >7 days between symptom documentation and test, and invalid test results were excluded. Results: Of 473 children tested at 1 site, 21 children had positive SARs-CoV-2 results and 452 children had negative results (4.4% positivity rate). Moreover, 85.7% of SARS-CoV-2–positive children had a known exposure to COVID-19 (Table 1). Of SARS-CoV-2–positive children, 61.9% had >1 symptom. Also, 52.4% of SARS-CoV-2–positive children had at least 1 symptom (fever, cough, or loss of taste or smell) versus 62.8% of SARS-CoV-2–negative children (Table 2). Runny nose or nasal congestion was the most frequently reported symptom in the SARS-CoV-2–positive group (47.6%) as well as the SARS-CoV-2–negative group (58.6%). Also, 14.3% of SARS-CoV-2–positive children had eye redness or discharge versus 3.1% of SARS-CoV-2–negative children. Isolated runny nose presented in 10.8% of SARS-CoV-2–negative versus 9.5% of SARS-CoV-2–positive children. All children with isolated diarrhea (n = 5), isolated headache (n = 3), and isolated rash (n = 2) tested negative. Preliminary symptom data based on 176 children from a second site showed that 9.9% of symptomatic children had a positive test result. Conclusions: Runny nose or nasal congestion was the most frequently reported symptom in all children tested for SARS-CoV-2. However, isolated runny nose or nasal congestion identified 2 cases of COVID-19 in our cohort. Eye redness or discharge may be an important symptom to screen for COVID-19 in children. Further research with a larger number of positive cases is needed to make conclusions about improving efficiency and efficacy of symptom screeners for COVID-19 in children. Funding: No Disclosures: None Cambridge University Press 2021-07-29 /pmc/articles/PMC9551572/ http://dx.doi.org/10.1017/ash.2021.107 Text en © The Society for Healthcare Epidemiology of America 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Covid-19 Zhou, Geena Singh, Prachi Perito, Emily R. Bardach, Naomi Penwill, Nicole Burrough, William Cheung, Ann Nguyen, Margaret Mittal, Shalini Cheng, Grace Spad, Mia-Ashley Optimizing COVID-19 Symptom Screening in the Pediatric Population |
title | Optimizing COVID-19 Symptom Screening in the Pediatric Population |
title_full | Optimizing COVID-19 Symptom Screening in the Pediatric Population |
title_fullStr | Optimizing COVID-19 Symptom Screening in the Pediatric Population |
title_full_unstemmed | Optimizing COVID-19 Symptom Screening in the Pediatric Population |
title_short | Optimizing COVID-19 Symptom Screening in the Pediatric Population |
title_sort | optimizing covid-19 symptom screening in the pediatric population |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551572/ http://dx.doi.org/10.1017/ash.2021.107 |
work_keys_str_mv | AT zhougeena optimizingcovid19symptomscreeninginthepediatricpopulation AT singhprachi optimizingcovid19symptomscreeninginthepediatricpopulation AT peritoemilyr optimizingcovid19symptomscreeninginthepediatricpopulation AT bardachnaomi optimizingcovid19symptomscreeninginthepediatricpopulation AT penwillnicole optimizingcovid19symptomscreeninginthepediatricpopulation AT burroughwilliam optimizingcovid19symptomscreeninginthepediatricpopulation AT cheungann optimizingcovid19symptomscreeninginthepediatricpopulation AT nguyenmargaret optimizingcovid19symptomscreeninginthepediatricpopulation AT mittalshalini optimizingcovid19symptomscreeninginthepediatricpopulation AT chenggrace optimizingcovid19symptomscreeninginthepediatricpopulation AT spadmiaashley optimizingcovid19symptomscreeninginthepediatricpopulation |